Caplin Point Labs News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Caplin Point Laboratories Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Caplin Point Laboratories Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on Caplin Point Labs from all sources in a single place.

Caplin Point Laboratories Ltd.

06 Jun 2026

2334.90

-1.80%

Movers & Shakers: Stocks that will see action this week

Business Line

Here is what the charts say about the shares of Caplin Point Laboratories, Kalyan Jewellers India and Quess Corp

Caplin Point Laboratories Ltd. is trading above all available SMAs

Caplin Point Laboratories Ltd.

29 May 2026

2334.90

-1.80%

Company Update

Caplin Point Laboratories Ltd - 524742 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance report for the year ended March 31, 2026

pdf

Caplin Point Laboratories Ltd.

22 May 2026

2334.90

-1.80%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Caplin Point Laboratories Ltd.

21 May 2026

2334.90

-1.80%

Earnings Call

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript for Earnings call- Q4- FY 2025-26

pdf

Caplin Point Laboratories Ltd.

15 May 2026

2334.90

-1.80%

Caplin Point Laboratories

Buy: Caplin Point Laboratories ...

Target

ICICI Direct

Caplin Steriles caters mainly to the US and other regulated markets. So far, it has developed and filed 65 ANDAs in the US on its own and with partners, with 59 approvals as on date. The Company is also working on a portfolio of 55+ simple and complex Injectable and Ophthalmic products,...

Number of FII/FPI investors decreased from 174 to 165 in Mar 2026 qtr

Caplin Point Laboratories Ltd.

14 May 2026

2334.90

-1.80%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release regarding receipt of final approval by our subsidiary, Caplin Steriles Limited, from USFDA, for Foscarnet Sodium Injection

pdf

Caplin Point Laboratories Ltd.

14 May 2026

2334.90

-1.80%

Caplin Point Laboratories Results Earnings Call for Q4FY26 & Full Year

Conference Call with Caplin Point Laboratories Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Caplin Point Laboratories Ltd.

14 May 2026

2334.90

-1.80%

to see Rapid results content

Caplin Point Laboratories Ltd.

14 May 2026

2334.90

-1.80%

Corp. Action

Caplin Point Laboratories Ltd - 524742 - Corporate Action-Board approves Dividend

BSE India

The Board at its meeting held today, May 14, 2026, had declared Interim Dividend of INR.4.00 (200%) per equity share for the FY 2025-26 and fixed the Record date as May 30, 2026.

pdf

Caplin Point Laboratories Ltd.

14 May 2026

2334.90

-1.80%

Result

Caplin Point Laboratories Ltd - 524742 - Financial Results For The Quarter And Year Ended March …

BSE India

Financial Results for the Quarter and Year ended March 31, 2026

pdf

	Mar 2026	Dec 2025	Mar 2025	Change QoQ%	Change YoY%
Total Revenue Qtr	628.52	576.45	528.19	9.0%	19.0%
Operating Profit Qtr	204.24	189.69	168.06	7.7%	21.5%
Net Profit Qtr	170.11	163.88	142.57	3.8%	19.3%
Earning Per Share Adjusted latest Qtr	22.38	21.56	18.76	3.8%	19.3%

* Consolidated data

Detailed Results

Is Caplin Point Laboratories Ltd. worth buying?

495 Votes:

Buy 81.01%

Sell 12.12%

Hold 6.87%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf